- Home
- ORGO vs SAR Comparison
ORGO vs SAR Comparison
Compare ORGO & SAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORGO
- SAR
- Stock Information
- Founded
- ORGO 1985
- SAR 2007
- Country
- ORGO United States
- SAR United States
- Employees
- ORGO N/A
- SAR N/A
- Industry
- ORGO Biotechnology: Pharmaceutical Preparations
- SAR Investment Managers
- Sector
- ORGO Health Care
- SAR Finance
- Exchange
- ORGO Nasdaq
- SAR Nasdaq
- Market Cap
- ORGO 384.4M
- SAR 337.6M
- IPO Year
- ORGO N/A
- SAR 2007
- Fundamental
- Price
- ORGO $3.46
- SAR $24.46
- Analyst Decision
- ORGO Buy
- SAR Hold
- Analyst Count
- ORGO 2
- SAR 4
- Target Price
- ORGO $5.50
- SAR $24.75
- AVG Volume (30 Days)
- ORGO 911.8K
- SAR 135.7K
- Earning Date
- ORGO 08-07-2025
- SAR 07-08-2025
- Dividend Yield
- ORGO N/A
- SAR 12.27%
- EPS Growth
- ORGO N/A
- SAR 186.33
- EPS
- ORGO N/A
- SAR 2.02
- Revenue
- ORGO $458,760,000.00
- SAR $148,855,238.00
- Revenue This Year
- ORGO $2.62
- SAR N/A
- Revenue Next Year
- ORGO $12.46
- SAR $2.28
- P/E Ratio
- ORGO N/A
- SAR $12.11
- Revenue Growth
- ORGO 5.35
- SAR 3.57
- 52 Week Low
- ORGO $2.28
- SAR $21.10
- 52 Week High
- ORGO $6.71
- SAR $26.49
- Technical
- Relative Strength Index (RSI)
- ORGO 54.42
- SAR 52.06
- Support Level
- ORGO $3.13
- SAR $24.05
- Resistance Level
- ORGO $3.36
- SAR $24.44
- Average True Range (ATR)
- ORGO 0.21
- SAR 0.33
- MACD
- ORGO 0.08
- SAR 0.01
- Stochastic Oscillator
- ORGO 74.36
- SAR 54.90
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.
About SAR Saratoga Investment Corp New
Saratoga Investment Corp is a specialty finance company that provides customized financing solutions to U.S. middle-market businesses. The Company invests primarily in senior and unitranche leveraged loans and mezzanine debt, and, to a lesser extent, equity to provide financing for change of ownership transactions, strategic acquisitions, recapitalizations and growth initiatives in partnership with business owners, management teams and financial sponsors. Its objective is to create attractive risk-adjusted returns by generating current income and long-term capital appreciation from its debt and equity investments.